.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cerilliant
Federal Trade Commission
Novartis
UBS
McKesson
Harvard Business School
Teva
Fuji
Cantor Fitzgerald

Generated: November 20, 2017

DrugPatentWatch Database Preview

Patents Expiring in November 2024

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION
Allergan
SANCTURA XR
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL022103-001Aug 3, 2007DISCNYesNo► Subscribe► Subscribe METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION
Shire Dev Llc
XIIDRA
lifitegrast
SOLUTION/DROPS;OPHTHALMIC208073-001Jul 11, 2016RXYesYes► Subscribe► SubscribeYY
Shire Dev Llc
XIIDRA
lifitegrast
SOLUTION/DROPS;OPHTHALMIC208073-001Jul 11, 2016RXYesYes► Subscribe► SubscribeY
Shire Dev Llc
XIIDRA
lifitegrast
SOLUTION/DROPS;OPHTHALMIC208073-001Jul 11, 2016RXYesYes► Subscribe► Subscribe TREATMENT OF SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
Shire Dev Llc
XIIDRA
lifitegrast
SOLUTION/DROPS;OPHTHALMIC208073-001Jul 11, 2016RXYesYes► Subscribe► SubscribeYY TREATMENT OF SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
Glaxosmithkline Cons
FLONASE SENSIMIST ALLERGY RELIEF
fluticasone furoate
SPRAY, METERED;NASAL022051-002Aug 2, 2016OTCYesYes► Subscribe► SubscribeY
Janssen Pharms
XARELTO
rivaroxaban
TABLET;ORAL022406-003Nov 4, 2011RXYesYes► Subscribe► SubscribeY REDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
QuintilesIMS
Accenture
Chinese Patent Office
Federal Trade Commission
Merck
US Department of Justice
Mallinckrodt
Chubb
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot